Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
NCT03404752
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Peg-Filgrastim
Sponsor
Gema Biotech S.A.
Collaborators
[object Object]